Human Fungal Pathogens
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (30 November 2015) | Viewed by 14456
Special Issue Editor
Interests: antifungal drug development; human fungal pathogens (Candida, Cryptococcus, Aspergillus); plant fungal and bacterial pathogens (Fusarium and Streptomyces); biological control
Special Issue Information
Dear Colleagues
About 1.2 billion people worldwide are estimated to suffer from fungal infections and these infections have significantly increased in recent years due to the emergence of immunocompromised patients, such as those with AIDS and cancer. Among them, Candida, Cryptococcus, Aspergillus, and Fusarium are frequently isolated and associated with high mortality if not appropriately treated. However, current antifungal drugs, such as azoles, polyenes, echinocandins, and flucytosine are not sufficient to combat fungal infections. New compounds and novel formulations/combinations of existing antifungal drugs are under development and can potentially reduce fungal infections. In order to develop novel antifungal drugs, studying the basic mechanisms of microbial pathogenesis is pivotal. Therefore, we would like to create a Special Issue on “Human Fungal Pathogens”, focusing on antifungal drug development and microbial pathogenesis. We invite you to submit a research or review article related to these fields of fungal pathogens, and we are looking forward to your key contributions.
Dr. Ying-Lien Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Candida
- Cryptococcus
- Aspergillus
- Fusarium
- Antifungal drug development
- Microbial pathogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
